Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study

Parkinson's Disease
Javier PagonabarragaJaime J Kulisevsky

Abstract

Sleep disturbances occur frequently in patients with Parkinson's disease (PD). The aim of this study was to investigate the effects of rotigotine on sleep fluctuations in a sample of PD patients with self-reported complaints of nocturnal awakenings. This prospective, open-label, observational, and multicenter study enrolled consecutive outpatients with PD and administered rotigotine (mean dose 8.9 mg/day) for 3 months. The primary endpoint was the change from baseline in sleep fragmentation, assessed using the sleep maintenance subscale score of the Parkinson's Disease Sleep Scale (PDSS). The newly designed Parkinson's Disease Sleep Fragmentation Questionnaire (PD-SFQ) was used to measure other sleep parameters. A total of 62 patients were enrolled (mean age 70.2 years; 66% male). At 3 months, rotigotine significantly improved sleep fragmentation from baseline on the PDSS-2 sleep maintenance subscale (from 3.4 ± 0.9 to 1.9 ± 1.4; P < 0.0001). Rotigotine also significantly improved nocturnal motor symptoms (P < 0.0001), restless legs-like symptoms (P < 0.005), and nocturia (P = 0.004). Rotigotine significantly improved self-reported complaints of sleep fragmentation in PD patients and could be a useful treatment to improve this ...Continue Reading

References

Mar 1, 1992·Journal of Neurology, Neurosurgery, and Psychiatry·A J HughesA J Lees
Aug 1, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·G T Stebbins, C G Goetz
Nov 25, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·E TandbergK Karlsen
Apr 14, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·K H KarlsenJ G Maeland
Nov 20, 2002·Journal of Neurology, Neurosurgery, and Psychiatry·K R ChaudhuriC Trenkwalder
Nov 5, 2003·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·L PrianoA Mauro
Sep 20, 2005·Journal of Neurology, Neurosurgery, and Psychiatry·F S ErtanH Uyguçgil
Nov 5, 2005·CNS Drugs·Neil A ReynoldsStephanie E Easthope
Nov 14, 2006·Journal of Neurology, Neurosurgery, and Psychiatry·M D GjerstadJ P Larsen
Nov 29, 2007·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·B PorterR Walker
Nov 30, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Pengcheng HanPatrick J Whelan
Jan 5, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Cynthia L Comella
May 21, 2008·Nature Reviews. Neuroscience·Clare J FowlerWilliam C de Groat
Aug 16, 2008·Naunyn-Schmiedeberg's Archives of Pharmacology·Dieter SchellerHermann Lübbert
Apr 14, 2009·Parkinsonism & Related Disorders·M I NorlinahA A Raymond
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneUNKNOWN PRIAMO study group
Jan 16, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Ryuji SakakibaraMasahiko Kishi
Jan 27, 2010·Journal of Geriatric Psychiatry and Neurology·David G GunnSimon J G Lewis
Feb 4, 2010·Parkinsonism & Related Disorders·K Ray Chaudhuri, Kartik Logishetty
Oct 20, 2010·Journal of Neurology·Juan Carlos Gómez-EstebanJuan J Zarranz
Nov 3, 2010·The Journal of Neuropsychiatry and Clinical Neurosciences·Sharon L NaismithSimon J G Lewis
Nov 12, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Claire L TomlinsonCarl E Clarke
Feb 12, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderKallol Ray Chaudhuri
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Claudia TrenkwalderUNKNOWN Recover Study Group
Oct 22, 2011·Neurobiology of Disease·Ryuji SakakibaraTatsuya Yamamoto
Jan 15, 2013·Acta Neurologica Scandinavica·M ZibettiL Lopiano
Oct 15, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Gordon W DuncanDavid J Burn
Nov 16, 2013·Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine·Ariel B NeikrugSonia Ancoli-Israel
Apr 1, 2014·Journal of Neural Transmission·Pramon ViwattanakulvanidRoongroj Bhidayasiri

❮ Previous
Next ❯

Software Mentioned

SPSS
RECOVER

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
C TrenkwalderKallol Ray Chaudhuri
Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials
Min LiYi Liu
© 2021 Meta ULC. All rights reserved